polatuzumab vedotin,vedolizumab
takeda,roche
['pola', ' vedo', 'vedo', 'polatuzumab']
question for : how to approach bridging therapy pre-car-t? answer: her favourite bridging therapy is polatuzumab vedotin, unless contraindicated by debilitating neuropathy, but also uses chemotherapy and/or radiotherapy in some cases #asco23
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem